Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-14

Clinical Trial Update: Fentanyl for Breakthrough Pain in the Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating fentanyl for breakthrough pain in the emergency department was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2020-10-14